Impact and consequences of COVID-19 pandemic on complicated grief and persistent complex bereavement disorder.

Autor: Diolaiuti F; University of Pisa, Department Translational Research and New Technologies in Medicine and Surgery, Italy., Marazziti D; University of Pisa, Department of Clinical and Experimental Medicine, Section of Psychiatry, Italy; Saint Camillus International University of Health and Medical Sciences, Rome, Italy; BRF Foundation Lucca, Italy. Electronic address: dmarazzi@psico.med.unipi.it., Beatino MF; University of Pisa, Department Translational Research and New Technologies in Medicine and Surgery, Italy., Mucci F; University of Siena, Department of Biotechnology, Chemistry and Pharmacy, Italy., Pozza A; University of Siena, Department of Medical Sciences, Surgery and Neurosciences, Italy.
Jazyk: angličtina
Zdroj: Psychiatry research [Psychiatry Res] 2021 Jun; Vol. 300, pp. 113916. Date of Electronic Publication: 2021 Mar 31.
DOI: 10.1016/j.psychres.2021.113916
Abstrakt: Mourning is a coping-with-loss stage that prevents grief from becoming pathologic, i.e., complicated grief (CG) syndrome and persistent complex bereavement disorder (PCBD), recently included in international classification systems. During the COVID-19 pandemic, to contain virus spread, several countries adopted/adopt the prohibition of mourning rituals (funeral ceremonies/visiting to cemeteries), so that people were/are unable to give their hospitalized relatives the latest goodbye. Such measures can lead vulnerable individuals to develop CG and PCBD. We critically discuss literature-based risk factors for and protective resources against the onset of these conditions since the start of the pandemic and analyze prevention strategies to inform public health programs.
(Copyright © 2021 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: